B Steinsvik

Learn More
Antiangiogenic drugs are currently tested in haematological malignancies. As these drugs target different angiogenic regulators, and as cancers are inherently heterogeneous, a detailed characterization of angiogenesis in individual cancers is needed. Hence, we measured bone marrow microvessel density (MVD), plasma concentrations of eight(More)
BACKGROUND Postmenopausal hormone therapy (HT) is associated with an increased risk for arterial and venous thrombosis. OBJECTIVES To compare the impact of HT, tibolone, and raloxifene on C-reactive protein (CRP) and other inflammatory markers, and to investigate possible underlying mechanisms for changes in CRP and D-dimer. METHODS Two hundred and two(More)
  • 1